Real Women,
Real Insights,
Real Conversations
Women by and large are not having productive conversations with HCPs about birth control. Instead, they’re talking to each other about it. For the pill, you have to remember it every day, and for most women, who are overbooked, overstressed and under-supported, every day is a different kind of chaos. Having one more thing that you have to do amidst the crazy is not ideal. Having something that was only once a week AND wasn’t invasive would be a much better fit for women’s lives no matter where they were in their lives or birth control journey.
We focused on women talking to women about birth control. Used the authenticity of real conversations to legitimize a product they’d never heard about and a delivery system they may have questions about. And drew attention to the fact that, with a once-a-week application, Twirla was a significantly better fit for their lives than any other birth control.
RESULTS
Twirla had a successful product launch and is currently growing rapidly. Net revenue increased by 44% from Q1 to Q2 2023, and YOY the growth is 159% with targeted 2023 sales of $25 – $30 million. To continue to drive growth, Twirla promotional efforts are focused on five states that have high levels of reimbursement potential for Twirla and are estimated to reach over 45% of U.S. women between the ages of 18 and 24.